Status:
COMPLETED
Evaluation of Intravenous N-acetylcysteine to Prevent Contrast Media Induced Nephrotoxicity in an Emergency Center
Lead Sponsor:
University Hospital, Geneva
Conditions:
Nephrotoxicity
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the present study is to determine whether a high dose of intravenous NAC is efficient in preventing CN after emergency contrast injection in patients with renal failure.
Detailed Description
Prevention of acute kidney injury (AKI) post contrast injection remains mandatory given its association to morbidity and mortality1. Contrast nephropathy (CN) was classically defined as an increase i...
Eligibility Criteria
Inclusion
- Renal failure and need of contrast enhanced CT
Exclusion
- Asthma
- Pregnancy
- Obstructive nephropathy
- Patient or family's refusal
- In all patients
Key Trial Info
Start Date :
May 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2011
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT01467154
Start Date
May 1 2008
End Date
November 1 2011
Last Update
November 9 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.